Rbm20 ablation is associated with changes in the expression of titin-interacting and metabolic proteins

Eli J Larson1, Zachery R Gregorich2, Yanghai Zhang2

  • 1Department of Chemistry, University of Wisconsin-Madison, Madison, WI, USA.

Molecular Omics
|June 28, 2022
PubMed

Insights

Genetic ablation of RNA binding motif protein 20 (Rbm20) causes dilated cardiomyopathy (DCM) in rats. Proteomic analysis revealed altered titin interactions and mitochondrial metabolism, contributing to DCM development.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Proteomics

Background:

  • Dilated cardiomyopathy (DCM) is a leading cause of heart failure and arrhythmia.
  • Mutations in RNA binding motif protein 20 (Rbm20) are linked to DCM.
  • The precise molecular mechanisms underlying Rbm20-associated DCM are not fully understood.

Purpose of the Study:

  • To investigate the cardiac proteomic changes in Rbm20 knockout (KO) rat hearts.
  • To elucidate the molecular pathways contributing to DCM development in the absence of Rbm20.

Main Methods:

  • Global quantitative proteomics was employed on cardiac tissue from Rbm20 KO rats.
  • Comparative proteomic analysis was performed to identify differentially expressed proteins.

Main Results:

  • Significant alterations were observed in titin-interacting proteins, suggesting impaired mechanical stretch signaling.
  • Changes in mitochondrial enzymes indicate altered mitochondrial metabolism and potential dysfunction.
  • These proteomic shifts provide insights into pathological hypertrophy and metabolic dysregulation in Rbm20 KO hearts.

Conclusions:

  • Genetic ablation of Rbm20 leads to DCM through complex molecular alterations.
  • The study highlights the role of titin interactions and mitochondrial function in Rbm20-mediated cardiac pathology.
  • This is the first report detailing cardiac proteome changes associated with Rbm20 deficiency.